Press releases


  • 23/02/2017 - Idinvest Partners opens new Shanghai office to support the internationalisation of its portfolio companies

    Idinvest Partners, the specialist European SME investor, has established a Shanghai office to support the growth of its portfolio companies in Asian markets. The office will be led by Solomon Moos, Corporate Development Asia, who joined Idinvest in July 2016 from Allianz Global Investors. Solomon will be supported by three Chinese partners.This marks the most recent milestone in Idinvest's strategic international development and ability to offer in-country support to portfolio companies with hypergrowth ambitions, coming shortly after the opening of a Frankfurt office earlier this month. Christophe Baviere, CEO of Idinvest commented, "This latest development is part of our commitment to internationalise and facilitate the growth of our portfolio companies into global SMEs."

  • 21/02/2017 - Idinvest's UK Entrepreneurship Barometer shows 44% of population says UK best country to start a business

    Idinvest Partners today launched an annual study into the UK's attitudes towards entrepreneurship. Idinvest's UK Entrepreneurship Barometer measures the concerns of the next generation of entrepreneurial talent and therefore addresses the health of the UK's innovation ecosystem. In its first year, the Barometer poses questions about Brexit consequences, personal motivations, fundraising challenges and economic climate. Despite concerns that Brexit might diminish the UK's position as one of Europe's leading business hubs, 44% of the UK population still consider it the best country to start a business, beating rivals Germany by a strong margin. These findings can be seen as a vote of confidence in the outlook for the UK Economy with 57% of all respondents remaining optimistic for the country's economic performance over the next 12 months where participants were 10% more concerned by the European Economic outlook than that of the UK.

  • 09/02/2017 - Idinvest Partners expands European presence with Frankfurt office opening

    Idinvest Partners, a leader in financing the growth of European SME's, has announced the opening of a new office in Frankfurt along with new additions to its team. This new office highlights Idinvest's resolve to develop further internationally and offer dedicated in-country support to assist the growth of its portfolio companies.As both a former subsidiary of the Allianz Group, and by financing the growth of German companies, the establishment of a Frankfurt office marks the latest step in the strong relationship that Idinvest has maintained with the German market, particularly in its support of German companies via private debt financing, whether senior or subordinate. In addition, Idinvest has added three German nationals to its private debt team, and the new Frankfurt office will be represented by Florian Zimmerman, who has been working with Idinvest since 2014.

  • 06/02/2017 - Idinvest Partners announces the appointment of Alban Wyniecki as Investment Director

    Idinvest Partners is pleased to announce the appointment of Alban Wyniecki as an Investment Director. Alban will provide strategic direction and oversight of Idinvest's Growth Capital Fund II, which recently held its first close at €250 M. The fund's first investment this year was in Vestiaire Collective, an online e-commerce marketplace for pre-loved clothes. "We are very much looking forward to Alban joining the Growth team here at Idinvest," says Benoist Grossmann, Managing Partner at Idinvest. "We are currently seeing a good amount of opportunity for European companies looking to scale-up, particularly in the tech sector and where Alban brings a huge amount of expertise."

  • 19/01/2017 - Kurma Partners, Idinvest's investment manager in the health sector, is experimenting with a new investment model

    The idea is to syndicate with industry partners from the get-go, bringing them in at a pre-seed stage, prior to forming the company, to provide expertise that matches the newco's technology. Moreover, it should allow Kurma to compete for seed or series A stage assets with the bigger players. According to managing partner Vanessa Malier, the new approach is unique among French life science investors and makes it possible for a small firm like Kurma to create new companies without tying up a large percentage of its capital in seed investments. The firm's industry partners for these investments include Boehringer Ingelheim GmbH and Ionis Pharmaceuticals Inc. Kurma's target is to split its capital 40-60 between newcos and standard venture investments, with a goal of creating one to two new companies each year. While it makes investments all over Europe and occasionally in the U.S., Kurma is focusing the new platform in France.



News